Walgreens Boots Alliance
Explore Walgreens Boots Alliance
Core profile pages, annual revenue records, and related research hubs for this company.
Leadership History
3 leaders · 1901 to present
Walgreens is a private retail pharmacy company rooted in the 1901 Walgreen drugstore. The former Walgreens Boots Alliance public company reported $147.7 billion in FY2024 sales before Sycamore completed the 2025 take-private.
Walgreens earns from prescription pharmacy, front-end retail, immunizations, health services, specialty pharmacy relationships, loyalty-driven retail activity, and partnerships across the pharmacy ecosystem. The current private-company model is narrower and more operationally focused than the old public WBA story. Management is emphasizing core pharmacy execution, store productivity, cost discipline, and selective healthcare services after the VillageMD strategy destroyed significant value.
Walgreens CEO
2025 – Present
1 year (current)
Leads Walgreens as a private standalone company after Sycamore completed the WBA acquisition.
Former WBA CEO
2023 – 2025
2 years
Led the public WBA turnaround period before the Sycamore take-private; continues in board context after the transaction.
Founder
1901 – 1939
38 years
Founded Walgreens and built the pharmacy-retail culture around service, consistency, and convenience.
Walgreens still faces pharmacy reimbursement compression, labor costs, shrink, weak front-store traffic, lease obligations, Amazon and mail-order pharmacy competition, CVS vertical integration, and the need to close or fix underperforming stores without losing pharmacy customers.
Private ownership gives management more room to restructure away from public-market pressure, but it also means the company must carry turnaround execution under leveraged-buyout economics.
Mike Motz is listed as Walgreens's current CEO in this profile.
The leadership agenda centers on pharmacy execution, store productivity, cost discipline, and private-company restructuring.
Leadership changes help explain shifts in capital allocation, product priorities, and competitive positioning.
Leadership eras map to the shift from public global pharmacy group to private standalone Walgreens turnaround.